Anupam Rasayan approves FY26 results, INR 1.5 dividend and Bliss GVS stake acquisition
Anupam Rasayan India · Chemicals & Petrochemicals
Key highlights
- Board approved audited standalone and consolidated results for quarter and year ended March 31, 2026; auditor opinions are unmodified
- Recommended final dividend of INR 1.5 per equity share (15% of face value of INR 10), subject to AGM approval
- Board approved acquiring up to 74.20% stake and control of Bliss GVS Pharma Limited; filing states no value
Why it's rated notable: The board approved acquiring up to 74.20% and control of listed Bliss GVS Pharma Limited, but the filing states no consideration, so the level is medium by default and the event is not shown as definite.
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Corporate Action-Board approves Dividend
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Anupam Rasayan India
- Acquisition / mergerNotableAnupam Rasayan completes acquisition of 48.2% controlling stake in Bliss GVS Pharma
- Board / shareholder meeting outcomeNotableAnupam Rasayan India Ltd approves 23rd AGM, dividend record date, Tanfac share acquisition
- Order winNotableAnupam Rasayan signs six-year supply contract with US specialty metal firm
- Fundraise / allotmentMajor developmentAnupam Rasayan India Ltd credit rating updated by Crisil Ratings Limited
- Fundraise / allotmentNotableAnupam Rasayan India Ltd announces FY26 results, dividend, auditors, and acquisition plans
Other fundraise / allotment filings this fortnight
- IIFL Finance Limited announces preferential issue of shares and amendments on Nov 10, 2026
- IIFL Finance to raise ₹6,414 crore in primary equity infusion led by Blackstone
- Bajaj Finserv subscribes to 5,74,25,740 Bajaj Finance warrants at ₹1,010 each
- Supreme Engineering allots 14,50,00,000 warrants at ₹2.60 on preferential basis
- Bajaj Finance Limited allots 5.74 crore warrants to Bajaj Finserv on 10 Nov 2026
- Bajaj Finance approves preferential issue of 5.74 crore warrants to Bajaj Finserv
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.